EFFICACY, TOXICITY AND DOSIMETRIC ASPECTS OF HDR BRACHYTHERAPY IN PROSTATE CANCER PATIENTS: 4 YEARS EXPERIENCE

被引：0
|
作者：
Filipowski, T. [1 ]
Dorota, K. [1 ]
Anna, S. T. [1 ]
Wiktor, N. [2 ]
Barbara, P. J. [2 ]
机构：
[1] Bialostockie Ctr Onkol, Dept Radiotherapy, Bialystok, Poland
[2] Bialostockie Ctr Onkol, Dept Med Phys, Bialystok, Poland
来源：
RADIOTHERAPY AND ONCOLOGY | 2011年 / 99卷
关键词：
D O I：
10.1016/S0167-8140(11)70828-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
706
引用
收藏
页码：S282 / S282
页数：1
相关论文
共 50 条
  • [31] The dosimetric impact of interstitial needles in HDR brachytherapy for cervical cancer
    Otter, S.
    Coates, A.
    Franklin, A.
    Brennan, C.
    Cunningham, M.
    Stewart, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127
  • [32] HDR brachytherapy for carcinoma ef the prostate:: German experience
    Kovács, G
    Galalae, R
    Loch, T
    Dinges, S
    Deger, S
    Andreopoulos, D
    Papadpoulos, P
    Wolff, J
    Feldmann, H
    Hofman, R
    [J]. BRACHYTHERAPY FOR THE 21ST CENTURY, 1998, : 198 - 210
  • [33] HDR Brachytherapy as Monotherapy for Prostate Cancer: Early Toxicity of a Randomized Phase II Trial
    Jolicoeur, M.
    Derashodian, T.
    Nguyen-Huynh, T.
    Hillmann, E. de Castro
    Berbiche, D.
    Truchon, D.
    Heliou, R.
    Mondat, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S90 - S91
  • [34] A Pilot Study of Salvage HDR Brachytherapy in Recurrent Prostate Cancer: Toxicity Profile and Outcomes
    Foster, W.
    Martin, A. G.
    Vigneault, E.
    Lavallee, M. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E232 - E233
  • [35] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [36] MRI guided focal HDR brachytherapy in patients with localized prostate cancer
    Maenhout, M.
    van Zyp, J. R. N. Van der Voort
    Moerland, M. A.
    Koelink, M. R.
    Van Vliet-van den Ende, K. M.
    De Vries, J. H. W.
    Van Vulpen, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S154 - S154
  • [37] RTOG versus CTCAE score: reporting toxicity of HDR brachytherapy Monotherapy for prostate cancer
    Jolicoeur, M.
    Hill, E.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S71 - S71
  • [38] The dosimetric quality of brachytherapy implants in patients with small prostate volume depends on the experience of the brachytherapy team
    Liu, Hong-Wei
    Malkoske, Kyle
    Sasaki, David
    Bews, Jeff
    Demers, Alain
    Nugent, Zoann
    Ong, Aldrich
    Bashir, Bashir
    Dufan, Tarek
    Cho, Patrick
    Drachenberg, Darryl
    Chowdhury, Amit
    [J]. BRACHYTHERAPY, 2010, 9 (03) : 202 - 207
  • [39] Analysis of PSA kinetics after HDR brachytherapy in prostate cancer patients
    Burchardt, W.
    Skowronek, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S948 - S948
  • [40] Hypofractionated EBRT and single fraction HDR brachytherapy for patients with prostate cancer
    Kazberuk, D. E.
    Filipowski, T. M.
    Szmigiel-Trzcinska, A.
    Niksa, M.
    Hempel, D.
    Topczewska-Bruns, J.
    Nowik, W.
    Pancewicz-Janczuk, B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S973 - S973
12345